Plano Brasileiro de Preparação para Enfrentamento de uma Pandemia de Influenza

Objectives

Brazil’s influenza-pandemic framework provides flexible, integrated national guidance for preparedness, response and recovery before, during and after a pandemic. It is intended to organise action across the Unified Health System and other sectors, reduce morbidity, mortality and socio-economic disruption, protect essential services, and enable guidance to be revised as epidemiological circumstances evolve.[1][2]The framework covers the continuum from animal influenza threats and limited human transmission to sustained community transmission, post-peak periods, possible new waves and post-pandemic recovery.[3][4]

• Strengthen prevention, rapid notification, detection, epidemiological surveillance and response capacity to reduce the effects of pandemic influenza.[5]
• Delay the introduction and spread of a pandemic strain, contain early transmission where feasible, and shift to mitigation through monitoring and prioritised care when sustained transmission occurs.[6]
• Protect the population through active surveillance, early detection of new influenza subtypes, prompt notification of potentially transmissible agents, and measures addressing geographical spread, intensity, impact and trends.[7][8]
• Reduce influenza-related morbidity and mortality by strengthening comprehensive health care, including health promotion, prevention, treatment, rehabilitation, clinical protocols, referral pathways and expanded care capacity.[9]
• Strengthen laboratory diagnosis, integrated human and animal health surveillance, immunisation preparedness, infection prevention and control, and pharmacovigilance for vaccines and antivirals.[8][10][11][12]
• Protect travellers, transport workers, rural communities, port and airport personnel, and the wider public while maintaining the movement of people, cargo, supplies and essential transport operations as far as possible.[13][14][15]
• Reduce wider social and economic effects through continuity planning for ports, aviation, borders, agro-industry, trade and other essential national functions.[2][16][17]

Implementation

Implementation uses a whole-of-government, multi-level model led by the Ministry of Health and coordinated through the Interministerial Executive Group, with federal, state and municipal authorities, health services, regulatory bodies, laboratories, transport organisations, agricultural institutions, defence bodies, scientific centres, international partners and communities contributing according to their responsibilities.[18][5][14]The approach combines World Health Organization pandemic phases, scenario-based planning, dynamic modelling, surveillance-led risk assessment, contingency arrangements and continuous review of response effectiveness.[19][20]

• Coordinate national preparedness and response through the Ministry of Health, which leads epidemiological and health surveillance, health-care and laboratory functions, containment and mitigation measures, clinical-management regulation, risk communication, logistics, and support for state and municipal plans.[6]
• Apply pandemic-phase and scenario-based planning, including low, intermediate and high assumptions for transmissibility, morbidity, mortality and treatment effectiveness, to guide proportionate interventions and transparent communication.[19][20]
• Operate surveillance through the Health Surveillance Secretariat, the Centre for Strategic Information and Response in Health Surveillance and its network, which manage event information, assess epidemiological signals, support field investigations and coordinate emergency response structures.[21][22]
• Modernise emergency operations capacity, establish protocols for information units and networks, train state and municipal teams in outbreak investigation, and link hospital epidemiology units with surveillance networks.[23]
• Coordinate laboratory diagnosis through the National Network of Epidemiological Surveillance Laboratories, standardise sample collection and transport, procure laboratory supplies, train personnel and monitor viral circulation, mutations and antiviral resistance.[8][10]
• Secure, store and distribute antivirals, immunological products, diagnostic tests and other strategic inputs, while maintaining cold-chain standards and coordinating pandemic vaccine procurement, production and deployment.[6][24][25]
• Monitor vaccination coverage daily by priority group, municipality and federative unit; analyse distributed and administered doses and adverse events; and investigate serious events following immunisation in coordination with the National Health Surveillance Agency and vaccine manufacturers.[26]
• Strengthen health-service delivery by equipping outpatient and hospital services, developing care pathways, expanding beds and advanced life-support capacity, training the workforce, and coordinating performance monitoring with state and municipal authorities.[9][27]
• Implement risk communication through coordinated public information, audience-specific and multilingual materials, an up-to-date influenza website, and monitoring of rumours and misinformation on social media.[27][13]
• Maintain sanitary and operational measures at ports, airports and borders, including traveller and cargo controls where indicated, inspection staffing, cleaning and waste-management oversight, local contingency plans, liaison arrangements and continuity planning.[13][28][16][29]
• Integrate animal-health, agricultural, rural-extension and transport actions through zoo-sanitary surveillance, laboratory analysis, movement controls, rural education, intersectoral information sharing and personnel training.[14][30][15]
• Monitor implementation through monthly reports to participating bodies, surveillance of transmission and severity, review of response measures during post-peak and post-pandemic periods, and inspection, notification and safety-alert functions.[5][4][12]The material does not specify a single consolidated quantitative performance framework or pandemic-specific budget.[2][31]

Monitoring & Evaluation

Monitoring and evaluation are centred on epidemiological surveillance, timely notification, coordinated information management and review of response actions across pandemic phases. The framework assigns monitoring functions to national surveillance bodies, health authorities and sectoral partners, but does not establish a single consolidated performance framework with universal numerical targets.[5][23][8]

• Monitor pandemic risk through surveillance of case detection, geographical spread, intensity, impact, trends, hospital admissions for respiratory disease, transmission patterns, clusters, severe illness, deaths and emerging influenza subtypes.[20][7][8]
• Assess severity using case-fatality rates, unusual severe disease, unexpected mortality, complications and the effectiveness of interventions, with phase transitions informed by changes in human-to-human transmission.[20][3][4]
• Track post-peak declines and possible new waves through effective surveillance, and evaluate responses, recovery and preparedness for subsequent waves during post-peak and post-pandemic periods.[3][4]
• Coordinate surveillance through the Health Surveillance Secretariat and the Centre for Strategic Information and Response in Health Surveillance, which manage event information, monitor epidemiological signals, support investigations, coordinate the CIEVS network and report internationally significant events to the World Health Organization.[21][22]
• Verify event information against International Health Regulations criteria, including public-health impact, unusual events, international-spread risks and possible travel or trade restrictions, and consolidate information through the CIEVS Monitor and Emergency Checklist.[22]
• Update notification, investigation and monitoring protocols; adapt information-recording tools; and integrate clinical, virological, epidemiological and laboratory data, including monitoring of viral mutations, antiviral resistance, animal sources and risks of human transmission.[23][8][10]
• Monitor vaccination daily by priority group, municipality and federative unit, including doses distributed and administered, coverage, adverse events and vaccination progress among specified age and priority groups.[26]
• Detect, notify and investigate serious adverse events following immunisation promptly; support all 27 federative units to enter information into the Adverse Events Following Immunisation Information System; and communicate serious events to the National Health Surveillance Agency and manufacturers.[26]
• Conduct pharmacovigilance for pandemic H1N1 antivirals and vaccines through post-marketing and post-use surveillance, safety-signal assessment, periodic report review, safety alerts and investigations of unexpected increases in adverse events.[12][14]
• Monitor delivery functions across care, communication, borders, transport and trade, including health-service performance, sanitation controls at ports, airports and borders, misinformation on social media, transport-operator compliance, port operational effects and influenza-related trade impacts.[9][27][13][16]
• Report progress monthly to the heads of participating bodies and monitor the execution of preventive actions and allocation of budgetary and financial resources.[5]

Quantitative indicators are specified only in limited operational areas, particularly surveillance attributes and vaccination coverage. The material does not specify common evaluation methods, audit procedures, reporting templates, comprehensive accountability targets or a uniform reporting timetable beyond monthly interministerial reports.[5][26][32][33]

Costing & Financing

Financing information is largely qualitative. The plan requires mobilisation and monitoring of resources for pandemic preparedness and response, identifies important supply, infrastructure and operational commitments, and refers to health-surveillance financing guidelines, but provides no pandemic-specific budget totals, cost estimates or quantified funding gaps.[5][31]

• Monitor the allocation of budgetary and financial resources needed to implement preparedness and response actions through the Interministerial Executive Group.[5]
• Optimise existing resources through timely planning and programming, while maintaining flexibility to adapt actions as pandemic circumstances change.[2]
• Secure and manage supplies of antivirals, immunological products, diagnostic tests, vaccines and other strategic inputs, including associated storage, cold-chain and distribution requirements.[6][24]
• Provide resource inputs for surveillance command-centre infrastructure, laboratory supplies, diagnostic capacity, health-worker training, health communication, border inspection and infection-control arrangements.[23][10][27][13]
• Acquire advanced life-support equipment, expand care beds and support alternatives where public health-system capacity is exhausted.[9]
• Finance construction and equipment acquisition for pandemic influenza vaccine production at the Butantan Institute through the Ministry of Health.[25]
• Seek working-capital credit for industrial recovery through the Brazilian Development Bank and other development bodies, and establish agreements intended to strengthen economic activity in epidemic-affected regions.[17]
• Commit non-monetary operational resources, including personnel, transport, logistics, military pharmaceutical production and six negative-pressure containers for infectious-disease patient transport.[34]

The material does not specify monetary allocations, unit costs, funding-source amounts, financing schedules, resource-mobilisation targets, economic assumptions, cost-effectiveness analyses or identified funding gaps. References to national financing guidelines and programme responsibilities do not quantify available or required resources.[31][24][25][16]